全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Diagnostic Accuracy of PCR in gambiense Sleeping Sickness Diagnosis, Staging and Post-Treatment Follow-Up: A 2-year Longitudinal Study

DOI: 10.1371/journal.pntd.0000972

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background The polymerase chain reaction (PCR) has been proposed for diagnosis, staging and post-treatment follow-up of sleeping sickness but no large-scale clinical evaluations of its diagnostic accuracy have taken place yet. Methodology/Principal Findings An 18S ribosomal RNA gene targeting PCR was performed on blood and cerebrospinal fluid (CSF) of 360 T. brucei gambiense sleeping sickness patients and on blood of 129 endemic controls from the Democratic Republic of Congo. Sensitivity and specificity (with 95% confidence intervals) of PCR for diagnosis, disease staging and treatment failure over 2 years follow-up post-treatment were determined. Reference standard tests were trypanosome detection for diagnosis and trypanosome detection and/or increased white blood cell concentration in CSF for staging and detection of treatment failure. PCR on blood showed a sensitivity of 88.4% (84.4–92.5%) and a specificity of 99.2% (97.7–100%) for diagnosis, while for disease staging the sensitivity and specificity of PCR on cerebrospinal fluid were 88.4% (84.8–91.9%) and 82.9% (71.2–94.6%), respectively. During follow-up after treatment, PCR on blood had low sensitivity to detect treatment failure. In cerebrospinal fluid, PCR positivity vanished slowly and was observed until the end of the 2 year follow-up in around 20% of successfully treated patients. Conclusions/Significance For T.b. gambiense sleeping sickness diagnosis and staging, PCR performed better than, or similar to, the current parasite detection techniques but it cannot be used for post-treatment follow-up. Continued PCR positivity in one out of five cured patients points to persistence of living or dead parasites or their DNA after successful treatment and may necessitate the revision of some paradigms about the pathophysiology of sleeping sickness.

References

[1]  Simarro PP, Jannin J, Cattand P (2008) Eliminating human African trypanosomiasis: Where do we stand and what comes next? PLoS Medicine 5: 174–180. doi: 10.1371/journal.pmed.0050055
[2]  Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P (2005) Options for the field diagnosis of human African trypanosomiasis. Clin Microbiol Rev 18: 133–146. doi: 10.1128/CMR.18.1.133-146.2005
[3]  Brun R, Blum J, Chappuis F, Burri C (2010) Human African trypanosomiasis. Lancet 375: 148–159. doi: 10.1016/S0140-6736(09)60829-1
[4]  Lejon V, Büscher P (2005) Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health 10: 395–403. doi: 10.1111/j.1365-3156.2005.01403.x
[5]  World Health Organization (1998) Control and surveillance of African trypanosomiasis. WHO Technical Report Series 881: 1–113.
[6]  Deborggraeve S, Büscher P (2010) Molecular diagnostics for sleeping sickness: where's the benefit for the patient? Lancet Infect Dis 10: 433–439. doi: 10.1016/S1473-3099(10)70077-3
[7]  Mumba Ngoyi D, Lejon V, Pyana P, Boelaert M, Ilunga M, et al. (2010) How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness? J Infect Dis 201: 453–463. doi: 10.1086/649917
[8]  Matovu E, Mugasa CM, Ali Ekangu R, Deborggraeve S, Lubega GW, et al. (2010) Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. PLoS Negl Trop Dis 4: e737. doi: 10.1371/journal.pntd.0000737
[9]  Woo PTK (1970) The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Trop 27: 384–386.
[10]  Miézan TW, Meda AH, Doua F, Djé NN, Lejon V, et al. (2000) Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg 94: 293. doi: 10.1016/S0035-9203(00)90327-4
[11]  Büscher P, Mumba Ngoyi D, Kaboré J, Lejon V, Robays J, et al. (2009) Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis 3: e471. doi: 10.1371/journal.pntd.0000471
[12]  World Health Organization (2007) Recommendations of the informal consultation on issues for clinical product development for human African trypanosomiasis. Geneva: WHO/CDS/NTD/IDM/2007.1. 73 p.
[13]  Radwanska M, Claes F, Magez S, Magnus E, Perez-Morga D, et al. (2002) Novel primer sequences for a polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am J Trop Med Hyg 67: 289–295.
[14]  Lutumba P, Meheus F, Robays J, Miaka C, Kande V, et al. (2007) Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis. Em Inf Dis 13: 1484–1490. doi: 10.3201/eid1310.060358
[15]  Truc P, Jamonneau V, Cuny G, Frézil JL (1999) Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. Bull World Health Organ 77: 745–748.
[16]  Kyambadde JW, Enyaru JCK, Matovu E, Odiit M, Carasco JF (2000) Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bull World Health Organ 78: 119–124.
[17]  Jamonneau V, Solano P, Garcia A, Lejon V, Djé N, et al. (2003) Stage determination and therapeutic decision in human African trypanosomiasis: value of PCR and IgM quantification on the cerebrospinal fluid of sleeping sickness patients in C?te d'Ivoire. Trop Med Int Health 8: 589–594. doi: 10.1046/j.1365-3156.2003.01079.x
[18]  Pentreath VW, Owolabi AO, Doua F (1992) Survival of Trypanosoma brucei brucei in cerebrospinal fluid. Ann Trop Med Parasitol 86: 29–34.
[19]  Doua F, Miézan TW, Sanon SR, Boa YF, Baltz T (1996) The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg 55: 586–588.
[20]  Lejon V, Legros D, Savignoni A, Gastellu Etchegorry M, Mbulamberi D, et al. (2003) Neuro-inflammatory risk factors for treatment failure in “early second stage” sleeping sickness patients treated with Pentamidine. J Neuroimmunol 144: 132–138. doi: 10.1016/j.jneuroim.2003.08.033
[21]  Gall Y, Woitag T, Bauer B, Sidibe I, McDermott J, et al. (2004) Trypanocidal failure suggested by PCR results in cattle field samples. Acta Trop 92: 7–16. doi: 10.1016/j.actatropica.2004.04.003
[22]  Jennings FW, Whitelaw DD, Holmes PH, Chizyuka HGB, Urquhart GM (1979) The brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapy. J Parasitol 9: 381–384. doi: 10.1016/0020-7519(79)90089-4
[23]  Miézan TW, Djé NN, Doua F, Boa F (2002) Trypanosomose humaine africaine en C?te d'Ivoire: caractéristiques biologiques après traitement. A propos de 812 cas traités dans le foyer de Daloa (C?te d'Ivoire). Bull Soc Pathol Exot Fil 95: 362–365.
[24]  Mbati PA, Hirumi K, Inoue N, Situakibanza NH, Hirumi H (1999) Towards developing a diagnostic regimen for the treatment follow-up of Trypanosoma brucei gambiense. Korean J Parasitol 37: 289–292. doi: 10.3347/kjp.1999.37.4.289
[25]  Garcia A, Jamonneau V, Magnus E, Laveissière C, Lejon V, et al. (2000) Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitemic individuals in C?te d'Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health 5: 786–793. doi: 10.1046/j.1365-3156.2000.00623.x
[26]  Kirchhoff LV (1998) Use of a PCR assay for diagnosing African trypanosomiasis of the CNS: a case report. Cent Afr J Med 44: 134–136.
[27]  Jamonneau V, Solano P, Cuny G (2001) Utilisation de la biologie moleculaire dans le diagnostic de la trypanosomose humaine africaine. Méd Trop 61: 347–354.
[28]  Schifferli JA, Taylor S (1989) Physiological and pathological aspects of circulating immune complexes. Kidney Int 35: 993–1003. doi: 10.1038/ki.1989.83
[29]  Kamei S, Takasu T, Morishima T, Mizutani T (2004) Serial changes of intrathecal viral loads evaluated by chemiluminescence assay and nested PCR with aciclovir treatment in herpes simplex virus encephalitis. Internal Medicine 43: 796–801. doi: 10.2169/internalmedicine.43.796
[30]  Pereira de Almeida PJL (1999) Contributions to the diagnostic evaluation of the Polymerase Chain Reaction for the detection of Salivarian trypanosomes [dissertation]. 195 p. Université Libre de Bruxelles, Brussels, Belgium.
[31]  Hecht MM, Nitz N, Araujo PF, Sausa AO, de Cássia Rosa A, et al. (2010) Inheritance of DNA transferred from American trypanosomes to human hosts. PLoS One 5: e9181. doi: 10.1371/journal.pone.0009181
[32]  Giroud C, Ottones F, Coustou V, Dacheux D, Biteau N, et al. (2009) Murine models for Trypanosoma brucei gambiense disease progression-from silent to chronic infections and early brain tropism. PLoS Negl Trop Dis 3: e509. doi: 10.1371/journal.pntd.0000509
[33]  Nikolskaia OV, Kim YV, Kovbasnjuk O, Kim KJ, Grab DJ (2006) Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier. Int J Parasitol 36: 513–519. doi: 10.1016/j.ijpara.2006.01.011
[34]  Stoppini L, Buchs P-A, Brun R, Muller D, Duport S, et al. (2000) Infection of organotypic slice cultures from rat central nervous tissue with Trypanosoma brucei brucei. Int J Med Microbiol 290: 105–113. doi: 10.1016/S1438-4221(00)80113-7
[35]  Claes F, Vodnala SK, Van Reet N, Boucher N, Lunden-Miguel H, et al. (2009) Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness patients. PLoS Negl Trop Dis 3: e486. doi: 10.1371/journal.pntd.0000486
[36]  Ngampo S (1992) Suivi post-thérapeutique des malades trypanosomés à T.b. gambiense. Problèmes et perspectives [dissertation]. 45 p. Instituut voor Tropische Geneeskunde, Antwerpen.
[37]  Robays J, Lefevre P, Lutumba P, Lubanza S, Kande Betu-Ku-Mesu V, et al. (2007) Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo. Trop Med Int Health 12: 290–298. doi: 10.1111/j.1365-3156.2006.01768.x
[38]  Njiru ZK, Mikosza ASJ, Matovu E, Enyaru JCK, Ouma JO, et al. (2008) African trypanosomiasis: Sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA. Int J Parasitol 38: 589–599. doi: 10.1016/j.ijpara.2007.09.006

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133